Gagliotti C - Search Results

1

Chikungunya virus in North-Eastern Italy: a seroprevalence survey.

Moro ML, Gagliotti C, Silvi G, Angelini R, Sambri V, Rezza G, Massimiliani E, Mattivi A, Grilli E, Finarelli AC, Spataro N, Pierro AM, Seyler T, Macini P; Chikungunya Study Group. Moro ML, et al. Among authors: gagliotti c. Am J Trop Med Hyg. 2010 Mar;82(3):508-11. doi: 10.4269/ajtmh.2010.09-0322. Am J Trop Med Hyg. 2010. PMID: 20207883 Free PMC article.

2

Quality of local guidelines for surgical antimicrobial prophylaxis.

Gagliotti C, Ravaglia F, Resi D, Moro ML. Gagliotti C, et al. J Hosp Infect. 2004 Jan;56(1):67-70. doi: 10.1016/j.jhin.2003.09.007. J Hosp Infect. 2004. PMID: 14706274

3

Side effects of antituberculosis therapy.

Resi D, Gagliotti C, Moro ML. Resi D, et al. Among authors: gagliotti c. Am J Respir Crit Care Med. 2004 Feb 15;169(4):542; author reply 542. doi: 10.1164/ajrccm.169.4.950. Am J Respir Crit Care Med. 2004. PMID: 14766664 No abstract available.

4

A three-year population-based study of antibiotic treatments for children.

Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML. Gagliotti C, et al. Acta Paediatr. 2005 Oct;94(10):1502-4. doi: 10.1111/j.1651-2227.2005.tb01827.x. Acta Paediatr. 2005. PMID: 16299886

5

Barriers to effective tuberculosis control: a qualitative study.

Moro ML, Resi D, Lelli B, Nicoli A, Gagliotti C, Falcone F. Moro ML, et al. Among authors: gagliotti c. Int J Tuberc Lung Dis. 2005 Dec;9(12):1355-60. Int J Tuberc Lung Dis. 2005. PMID: 16466058

6

Delay in the treatment of pulmonary TB in a changing demographic scenario.

Gagliotti C, Resi D, Moro ML. Gagliotti C, et al. Int J Tuberc Lung Dis. 2006 Mar;10(3):305-9. Int J Tuberc Lung Dis. 2006. PMID: 16562711

7

Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.

Gagliotti C, Nobilio L, Milandri M, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group. Gagliotti C, et al. Clin Infect Dis. 2006 Apr 15;42(8):1153-6. doi: 10.1086/501460. Epub 2006 Mar 6. Clin Infect Dis. 2006. PMID: 16575736

8

Antibiotic treatments for children ages 0-23 months in a northern Italy region: a cohort study.

Gagliotti C, Morsillo F, Resi D, Milandri M, Moro ML. Gagliotti C, et al. Infection. 2006 Jun;34(3):155-7. doi: 10.1007/s15010-006-5106-8. Infection. 2006. PMID: 16804659

9

Emergence of ciprofloxacin resistance in Escherichia coli isolates from outpatient urine samples.

Gagliotti C, Nobilio L, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group. Gagliotti C, et al. Clin Microbiol Infect. 2007 Mar;13(3):328-31. doi: 10.1111/j.1469-0691.2006.01615.x. Clin Microbiol Infect. 2007. PMID: 17391392 Free article.

10

Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.

Gagliotti C, Buttazzi R, Sforza S, Moro ML; Emilia-Romagna Antibiotic Resistance Study Group. Gagliotti C, et al. J Infect. 2008 Sep;57(3):179-84. doi: 10.1016/j.jinf.2008.07.004. Epub 2008 Aug 15. J Infect. 2008. PMID: 18707763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters